# IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.

> **NCT06160570** · NA · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 75 (actual)

## Conditions studied

- Rectal Cancer
- Radiotherapy
- Toxicity Due to Radiotherapy

## Interventions

- **RADIATION:** Intensive Modulated Radiation Therapy
- **RADIATION:** 3-Dimension Conformal Radiation Therapy

## Key facts

- **NCT ID:** NCT06160570
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06160570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06160570, "IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06160570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*